Molecular Mechanisms of Lovastatin-Induced Anti-cancer Effect in Human Anaplastic Thyroid Cancer Cells
博士 === 國立臺灣大學 === 生理學研究所 === 92 === Lovastatin has been used to treat hyperlipidemia through blocking the mevalonate biosynthesis pathway. Inhibition of mevalonate synthesis may result in anti-proliferation and cell apoptosis. The aim of the present study was to examine the apoptotic effe...
Main Authors: | Wen-Bin Zhong, 鍾文彬 |
---|---|
Other Authors: | Wen-Sen Lee |
Format: | Others |
Language: | zh-TW |
Published: |
2003
|
Online Access: | http://ndltd.ncl.edu.tw/handle/10918357394580010764 |
Similar Items
-
A Synergistic Anti-Cancer Effect of Troglitazone and Lovastatin in a Human Anaplastic Thyroid Cancer Cell Line and in a Mouse Xenograft Model
by: Wen-Bin Zhong, et al.
Published: (2018-06-01) -
Combined treatment with troglitazone and lovastatin inhibited epidermal growth factor-induced migration through the downregulation of cysteine-rich protein 61 in human anaplastic thyroid cancer cells.
by: Li-Han Chin, et al.
Published: (2015-01-01) -
Correction: Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells.
by: Li-Han Chin, et al.
Published: (2017-01-01) -
Anaplastic thyroid cancer
by: Javier Martínez Navarro, et al.
Published: (2017-10-01) -
Simvastatin Inhibits Cell Proliferation and Migration in Human Anaplastic Thyroid Cancer
by: Mei-Chieh Chen, et al.
Published: (2017-12-01)